Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:54127rdf:typepubmed:Citationlld:pubmed
pubmed-article:54127lifeskim:mentionsumls-concept:C0034721lld:lifeskim
pubmed-article:54127lifeskim:mentionsumls-concept:C0034693lld:lifeskim
pubmed-article:54127lifeskim:mentionsumls-concept:C0020550lld:lifeskim
pubmed-article:54127lifeskim:mentionsumls-concept:C0242202lld:lifeskim
pubmed-article:54127lifeskim:mentionsumls-concept:C0013030lld:lifeskim
pubmed-article:54127lifeskim:mentionsumls-concept:C0028351lld:lifeskim
pubmed-article:54127lifeskim:mentionsumls-concept:C0036751lld:lifeskim
pubmed-article:54127lifeskim:mentionsumls-concept:C0243127lld:lifeskim
pubmed-article:54127lifeskim:mentionsumls-concept:C1521828lld:lifeskim
pubmed-article:54127lifeskim:mentionsumls-concept:C0443331lld:lifeskim
pubmed-article:54127pubmed:issue3lld:pubmed
pubmed-article:54127pubmed:dateCreated1976-2-27lld:pubmed
pubmed-article:54127pubmed:abstractTextThe effect of chronic treatment with tyroxine (T4) or propylthiouracile (PTU) on the turnover of norepinephrine (NE), dopamine (DA) and 5-hydroxytryptamine (5-HT) has been studied in various areas of the rat brain (brain stem, hypothalamus, striatum and "rest of the brain"). The turnover of NE and DA was determined by the decay in endogenous levels after inhibition of tyrosine hydroxylase by alpha-methylparatyrosine and the turnover of 5-HT was evaluated by the initial accumulation of endogenous 5-HT after inhibition of monoamine oxydase by pargyline. T4 treatment accelerated the release of DA from the striatum but had no significant effects on NA release in the various cerebral areas : nevertheless the NE endogenous level was significantly reduced in the brain stem. PTU treatment delayed the release of DA and NA only from the "rest of the brain". Concerning 5-HT, the only significant variation was observed in the hypothalamus of PTU-treated rats and implied increased turnover. The possible relations between the changes in cerebral monoamines turnover and the behavioural alterations which are observed in thyroid disfunction are discussed.lld:pubmed
pubmed-article:54127pubmed:languagefrelld:pubmed
pubmed-article:54127pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:54127pubmed:citationSubsetIMlld:pubmed
pubmed-article:54127pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:54127pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:54127pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:54127pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:54127pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:54127pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:54127pubmed:statusMEDLINElld:pubmed
pubmed-article:54127pubmed:monthAuglld:pubmed
pubmed-article:54127pubmed:issn0003-9799lld:pubmed
pubmed-article:54127pubmed:authorpubmed-author:BeleyAAlld:pubmed
pubmed-article:54127pubmed:authorpubmed-author:BraletJJlld:pubmed
pubmed-article:54127pubmed:authorpubmed-author:BeleyPPlld:pubmed
pubmed-article:54127pubmed:issnTypePrintlld:pubmed
pubmed-article:54127pubmed:volume83lld:pubmed
pubmed-article:54127pubmed:ownerNLMlld:pubmed
pubmed-article:54127pubmed:authorsCompleteYlld:pubmed
pubmed-article:54127pubmed:pagination471-80lld:pubmed
pubmed-article:54127pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:54127pubmed:meshHeadingpubmed-meshheading:54127-An...lld:pubmed
pubmed-article:54127pubmed:meshHeadingpubmed-meshheading:54127-Br...lld:pubmed
pubmed-article:54127pubmed:meshHeadingpubmed-meshheading:54127-Ra...lld:pubmed
pubmed-article:54127pubmed:meshHeadingpubmed-meshheading:54127-Co...lld:pubmed
pubmed-article:54127pubmed:meshHeadingpubmed-meshheading:54127-Hy...lld:pubmed
pubmed-article:54127pubmed:meshHeadingpubmed-meshheading:54127-Th...lld:pubmed
pubmed-article:54127pubmed:meshHeadingpubmed-meshheading:54127-Se...lld:pubmed
pubmed-article:54127pubmed:meshHeadingpubmed-meshheading:54127-Ma...lld:pubmed
pubmed-article:54127pubmed:meshHeadingpubmed-meshheading:54127-Pr...lld:pubmed
pubmed-article:54127pubmed:meshHeadingpubmed-meshheading:54127-No...lld:pubmed
pubmed-article:54127pubmed:meshHeadingpubmed-meshheading:54127-Hy...lld:pubmed
pubmed-article:54127pubmed:meshHeadingpubmed-meshheading:54127-Hy...lld:pubmed
pubmed-article:54127pubmed:meshHeadingpubmed-meshheading:54127-Br...lld:pubmed
pubmed-article:54127pubmed:meshHeadingpubmed-meshheading:54127-Do...lld:pubmed
pubmed-article:54127pubmed:meshHeadingpubmed-meshheading:54127-Me...lld:pubmed
pubmed-article:54127pubmed:meshHeadingpubmed-meshheading:54127-Ty...lld:pubmed
pubmed-article:54127pubmed:year1975lld:pubmed
pubmed-article:54127pubmed:articleTitle[Influence of hypo- and hyperthyroidism on the turnover rate of noradrenaline, dopamine and serotonin in various rat cerebral structures].lld:pubmed
pubmed-article:54127pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:54127pubmed:publicationTypeEnglish Abstractlld:pubmed